Alamar Biosciences
ALMR
Alamar Biosciences (ALMR) news
Recent news
Alamar Biosciences names former Grail CEO Bob Ragusa to board of directors and expands leadership team
AInvest Wire · Oct 5, 2026Lancet Neurology study using Alamar Biosciences' technology reveals divergent biological responses to Alzheimer's treatment
A recent study published in The Lancet Neurology has highlighted divergent biological responses to Alzheimer's disease treatments, leveraging Alamar Biosciences' advanced proteomic technologies. The research, conducted using the NULISAseq CNS Disease Panel 120, analyzed plasma samples from 193…
AInvest Wire · Sep 24, 2026Alamar Biosciences outlook FY revenue $116 mln-$120 mln
AInvest Wire · Aug 10, 2026Alamar Biosciences Q2 revenue $29.4 million
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.